n-methyl-3,4-methylenedioxyamphetamine has been researched along with Headache in 4 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions." | 2.82 | Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. ( Breeksema, JJ; Kamphuis, J; Kuin, BW; Schoevers, RA; van den Brink, W; Vermetten, E, 2022) |
| "Previously, all reports of intracranial hemorrhages in MDMA abusers were associated with coingestion of other sympathomimetic drugs, or with pre-existing cerebrovascular lesions." | 1.38 | 3 cases of primary intracranial hemorrhage associated with "Molly", a purified form of 3,4-methylenedioxymethamphetamine (MDMA). ( Benveniste, RJ; Ferraro, N; Kahn, DE, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breeksema, JJ | 1 |
| Kuin, BW | 1 |
| Kamphuis, J | 1 |
| van den Brink, W | 1 |
| Vermetten, E | 1 |
| Schoevers, RA | 1 |
| Kahn, DE | 1 |
| Ferraro, N | 1 |
| Benveniste, RJ | 1 |
| Auer, J | 1 |
| Berent, R | 1 |
| Weber, T | 1 |
| Lassnig, E | 1 |
| Eber, B | 1 |
| Lee, GY | 1 |
| Gong, GW | 1 |
| Vrodos, N | 1 |
| Brophy, BP | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Headache
| Article | Year |
|---|---|
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
Topics: Banisteriopsis; Hallucinogens; Headache; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylened | 2022 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Headache
| Article | Year |
|---|---|
3 cases of primary intracranial hemorrhage associated with "Molly", a purified form of 3,4-methylenedioxymethamphetamine (MDMA).
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Anticoagulants; Aspirin; Cerebral Angiograph | 2012 |
Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult.
Topics: Adolescent; Cerebral Angiography; Headache; Hemiplegia; Humans; Intracranial Aneurysm; Male; N-Methy | 2002 |
'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication?
Topics: Adult; Basilar Artery; Brain; Cerebral Angiography; Cerebral Arteries; Female; Hallucinogens; Headac | 2003 |